Drug Hepatotoxicity
- 1 February 2017
- journal article
- research article
- Published by Elsevier in Clinics in Liver Disease
- Vol. 21 (1) , 115-134
Abstract
No abstract availableKeywords
This publication has 121 references indexed in Scilit:
- Incidence and relative risk of hepatic toxicity in patients treated with anti-angiogenic tyrosine kinase inhibitors for malignancyBritish Journal of Clinical Pharmacology, 2013
- Safety and Tolerability of Sitagliptin in Type 2 Diabetes: Pooled Analysis of 25 Clinical StudiesDiabetes Therapy, 2013
- Chemotherapy-Associated Liver Injury in Patients with Colorectal Liver Metastases: A Systematic Review and Meta-analysisAnnals of Surgical Oncology, 2012
- Susceptibility to Amoxicillin-Clavulanate-Induced Liver Injury Is Influenced by Multiple HLA Class I and II AllelesGastroenterology, 2011
- Erlotinib-induced Hepatotoxicity—Clinical Presentation and Successful Management: A Case ReportJournal of Clinical and Experimental Hepatology, 2011
- HLA-DQA1*02:01 Is a Major Risk Factor for Lapatinib-Induced Hepatotoxicity in Women With Advanced Breast CancerJournal of Clinical Oncology, 2011
- Maraviroc for Previously Treated Patients with R5 HIV-1 InfectionNew England Journal of Medicine, 2008
- Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- Erlotinib in Previously Treated Non–Small-Cell Lung CancerNew England Journal of Medicine, 2005
- Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid LeukemiaNew England Journal of Medicine, 2003